Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia

Critical Care Medicine

Volumn 39, Issue 9, 2011, Pages 2113-2120

  Le Berre, Rozenn ^a,b   Nguyen, Sophie ^a   Nowak, Emmanuel ^c   Kipnis, Eric ^a   Pierre, Maud ^a   Quenee, Lauriane ^f   Ader, Florence ^a   Lancel, Steve ^a   Courcol, René ^e   Guery, Benoît P ^a,d   Faure, Karine ^a,d  

^a UNIV LILLE   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e Lab de Bacteriologie Hygiene   (France)

^f Groupe de Recherche et d'Etude du Processus Inflammatoire   (France)

Author keywords

lipopolysaccharide; Pseudomonas aeruginosa; quorum sensing; type III secretion system; ventilator associated pneumonia; virulence factors

Indexed keywords

ELASTASE; EXOTOXIN; EXOTOXIN S; EXOTOXIN T; EXOTOXIN U; LIPOPOLYSACCHARIDE; PYOCYANINE; UNCLASSIFIED DRUG;

ALVEOLAR CAPILLIARY PERMEABILITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LUNG INJURY; LUNG WET DRY WEGHT RATIO; MALE; MOUSE; NONHUMAN; PERMEABILITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS PNEUMONIA; QUORUM SENSING; RISK ASSESSMENT; SEROTYPE; WEIGHT;

EID: 80051936857     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31821e899f     Document Type: Article

References (53)

1. Fagon JY, Chastre J, Hance AJ, et al: Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94: 281-288 (Pubitemid 23074802)
2. Bryan CS, Reynolds KL: Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 1984; 129:668-671 (Pubitemid 14104740)
3. Crouch BS, Wunderink RG, Jones CB, et al: Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996; 109: 1019-1029 (Pubitemid 26113647)
4. Sadikot RT, Blackwell TS, Christman JW, et al: Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 2005; 171:1209-1223 (Pubitemid 40740727)
5. Pesci EC, Pearson JP, Seed PC, et al: Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol 1997; 179: 3127-3132 (Pubitemid 27202984)
6. Whiteley M, Lee KM, Greenberg EP: Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. Proc Nat Acad Sci USA 1999; 96:13904-13909
7. Gambello MJ, Iglewski BH: Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression. J Bacteriol 1991; 173: 3000-3009
8. Brint JM, Ohman DE: Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family. J Bacteriol 1995; 177:7155-7163
9. Azghani AO: Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. Am J Respir Cell Mol Biol 1996; 15:132-140 (Pubitemid 126439864)
10. Mariencheck WI, Alcorn JF, Palmer SM, et al: Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. Am J Respir Cell Mol Biol 2003; 28:528-537 (Pubitemid 36399376)
11. Lau GW, Hassett DJ, Ran H, et al: The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med 2004; 10:599-606 (Pubitemid 39573151)
12. Hueck CJ: Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 1998; 62:379-433 (Pubitemid 28270280)
13. Barbieri JT, Sun J: Pseudomonas aeruginosa ExoS and ExoT. Rev Physiol Biochem Pharmacol 2004; 152:79-92 (Pubitemid 44404359)
14. Sitkiewicz I, Stockbauer KE, Musser JM: Secreted bacterial phospholipase A2 enzymes: Better living through phospholipolysis. Trends Microbiol 2007; 15:63-69 (Pubitemid 46199188)
15. Engel J, Balachandran P: Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 2009; 12:61-66
16. Yahr TL, Vallis AJ, Hancock MK, et al: ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Nat Acad Sci USA 1998; 95:13899-13904 (Pubitemid 28523070)
17. Rocchetta HL, Burrows LL, Lam JS: Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 1999; 63:523-553 (Pubitemid 29422781)
18. Pearson JP, Feldman M, Iglewski BH, et al: Pseudomonas aeruginosa cell-to-cell signaling is required for virulence in a model of acute pulmonary infection. Infect Immun 2000; 68:4331-4334 (Pubitemid 30434592)
19. Lesprit P, Faurisson F, Join-Lambert O, et al: Role of the quorum-sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats. Am J Respir Crit Care Med 2003; 167:1478-1482 (Pubitemid 37363355)
20. Lau GW, Ran H, Kong F, et al: Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 2004; 72: 4275-4278 (Pubitemid 38821943)
21. Ohman DE, Cryz SJ, Iglewski BH: Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol 1980; 142: 836-842 (Pubitemid 11230333)
22. Sawa T, Yahr TL, Ohara M, et al: Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat Med 1999; 5:392-398 (Pubitemid 29180576)
23. Vance RE, Rietsch A, Mekalanos JJ: Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun 2005; 73: 1706-1713 (Pubitemid 40470759)
24. Kurahashi K, Kajikawa O, Sawa T, et al: Pathogenesis of septic shock in Pseudomo-nas aeruginosa pneumonia. J Clin Invest 1999; 104:743-750 (Pubitemid 29536359)
25. Kudoh I, Wiener-Kronish JP, Hashimoto S, et al: Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am J Physiol 1994; 267:L551-L556 (Pubitemid 24351854)
26. Wiener-Kronish JP, Sakuma T, Kudoh I, et al: Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J Appl Physiol 1993; 75:1661-1669 (Pubitemid 23318215)
27. Finck-Barbancon V, Goranson J, Zhu L, et al: ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 1997; 25: 547-557 (Pubitemid 27373583)
28. Cryz SJ Jr, Pitt TL, Furer E, et al: Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun 1984; 44:508-513 (Pubitemid 14139022)
29. Fux CA, Shirtliff M, Stoodley P, et al: Can laboratory reference strains mirror 'realworld' pathogenesis? Trends Microbiol 2005; 13:58-63 (Pubitemid 40174864)
30. Roy-Burman A, Savel RH, Racine S, et al: Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 2001; 183:1767-1774 (Pubitemid 32523239)
31. Hauser AR, Cobb E, Bodi M, et al: Type III protein secretion is associated with poor clinical outcomes in patients with ventilatorassociated pneumonia caused by. Pseudomonas aeruginosa. Crit Care Med 2002; 30: 521-528 (Pubitemid 34214611)
32. Schulert GS, Feltman H, Rabin SD, et al: Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospitalacquired pneumonia. J Infect Dis 2003; 188: 1695-1706 (Pubitemid 38010681)
33. Storey DG, Ujack EE, Rabin HR, et al: Pseudomonas aeruginosa lasR transcription correlates with the transcription of lasA, lasB, and toxA in chronic lung infections associated with cystic fibrosis. Infect Immun 1998; 66:2521-2528 (Pubitemid 28261747)
34. LeBerre R, Nguyen S, Nowak E, et al: Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 2008; 14:337-343 (Pubitemid 351356524)
35. Yahr TL, Hovey AK, Kulich SM, et al: Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene. J Bacteriol 1995; 177:1169-1178
36. Yahr TL, Barbieri JT, Frank DW: Genetic relationship between the 53-and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa. J Bacteriol 1996; 178: 1412-1419 (Pubitemid 26073399)
37. Hauser AR, Kang PJ, Engel JN: PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence. Mol Microbiol 1998; 27:807-818 (Pubitemid 28081989)
38. Dacheux D, Attree I, Schneider C, et al: Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system. Infect Immun 1999; 67:6164-6167 (Pubitemid 29508152)
39. Sawa T, Corry DB, Gropper MA, et al: IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J Immunol 1997; 159:2858-2866 (Pubitemid 127681308)
40. Wiener-Kronish JP, Albertine KH, Matthay MA: Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 1991; 88:864-875
41. Faure K, Shimabukuro D, Ajayi T, et al: Oantigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa. J Clin Microbiol 2003; 41: 2158-2160 (Pubitemid 36576553)
42. Bleves S, Soscia C, Nogueira-Orlandi P, et al: Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAO1. J Bacteriol 2005; 187: 3898-3902 (Pubitemid 40705600)
43. Augustin DK, Song Y, Baek MS, et al: Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa. J Bacteriol 2007; 189: 2203-2209 (Pubitemid 46411334)
44. Veesenmeyer JL, Hauser AR, Lisboa T, et al: Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies. Crit Care Med 2009; 37:1777-1786
45. Blackwood LL, Stone RM, Iglewski BH, et al: Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection. Infect Immun 1983; 39:198-201 (Pubitemid 13212515)
46. Kon Y, Tsukada H, Hasegawa T, et al: The role of Pseudomonas aeruginosa elastase as a potent inflammatory factor in a rat air pouch inflammation model. FEMS Immunol Med Microbiol 1999; 25:313-321 (Pubitemid 29341555)
47. Sorensen RU, Klinger JD: Biological effects of Pseudomonas aeruginosa phenazine pigments. Antibiot Chemother 1987; 39: 113-124
48. Feltman H, Schulert G, Khan S, et al: Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. Microbiology 2001; 147: 2659-2669 (Pubitemid 32976307)
49. Allewelt M, Coleman FT, Grout M, et al: Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect Immun 2000; 68:3998-4004 (Pubitemid 30434552)
50. Ader F, Le BR, Faure K, et al: Alveolar response to Pseudomonas aeruginosa: Role of the type III secretion system. Infect Immun 2005; 73:4263-4271 (Pubitemid 40923169)
51. Shaver CM, Hauser AR: Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 2004; 72:6969-6977 (Pubitemid 39552365)
52. El Solh AA, Akinnusi ME, Wiener-Kronish JP, et al: Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am J Respir Crit Care Med 2008; 178:513-519
53. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, et al: Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 2007; 45: 979-989 (Pubitemid 46427721)